PL2792682T3 - Sposób wytwarzania stałej postaci octanu abirateronu - Google Patents
Sposób wytwarzania stałej postaci octanu abirateronuInfo
- Publication number
- PL2792682T3 PL2792682T3 PL13305517T PL13305517T PL2792682T3 PL 2792682 T3 PL2792682 T3 PL 2792682T3 PL 13305517 T PL13305517 T PL 13305517T PL 13305517 T PL13305517 T PL 13305517T PL 2792682 T3 PL2792682 T3 PL 2792682T3
- Authority
- PL
- Poland
- Prior art keywords
- producing
- solid form
- abiraterone acetate
- abiraterone
- acetate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305517.8A EP2792682B1 (en) | 2013-04-19 | 2013-04-19 | Process for producing a solid form of abiraterone acetate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2792682T3 true PL2792682T3 (pl) | 2017-04-28 |
Family
ID=48236826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13305517T PL2792682T3 (pl) | 2013-04-19 | 2013-04-19 | Sposób wytwarzania stałej postaci octanu abirateronu |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9920089B2 (pl) |
| EP (1) | EP2792682B1 (pl) |
| CN (1) | CN105143241B (pl) |
| ES (1) | ES2612780T3 (pl) |
| HR (1) | HRP20170139T1 (pl) |
| HU (1) | HUE033085T2 (pl) |
| IL (1) | IL242152B (pl) |
| PL (1) | PL2792682T3 (pl) |
| RS (1) | RS55673B1 (pl) |
| SI (1) | SI2792682T1 (pl) |
| WO (1) | WO2014170221A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2863500T3 (es) | 2015-04-10 | 2021-10-11 | Capsugel Belgium Nv | Formulaciones lipídicas de acetato de abiraterona |
| US20180200209A1 (en) * | 2015-07-10 | 2018-07-19 | Millendo Therapeutics, Inc. | Enhanced bioavailability of n-(2,6-bis(1-methylethyl)phenyl)-n'-((1-(4-(dimethylamino)-phenyl)cyclopentyl)methyl)urea hydrochloride |
| WO2018071544A1 (en) * | 2016-10-11 | 2018-04-19 | Zhuhai Beihai Biotech Co., Ltd. | Abiraterone derivative and formulations thereof |
| HU231297B1 (hu) * | 2018-07-31 | 2022-09-28 | Richter Gedeon Nyrt | Stabil gyógyszerkészítmények és eljárás az előállításukra |
| TWI830835B (zh) | 2018-12-17 | 2024-02-01 | 德商亞德維瑞醫藥有限公司 | 具改善性質之{4,6-二胺基-2-[5-氟-1-(2-氟芐基)-1H-吡唑並[3,4-b]吡啶-3-基]嘧啶-5-基}胺基甲酸甲酯活性化合物產物、其製造及調配物 |
| CN113307839A (zh) * | 2021-06-16 | 2021-08-27 | 马苏峰 | 一种制备醋酸阿比特龙结晶的方法及由此制得的醋酸阿比特龙结晶 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58143832A (ja) * | 1982-02-22 | 1983-08-26 | Yoshiaki Kawashima | 結晶性化学物質の球状化再結晶法 |
| DE69327096T2 (de) | 1992-03-31 | 2000-06-21 | Btg International Ltd., London | 17-substituierte steroide, verwendbar bei behandlung von krebs |
| EP0721461B1 (en) | 1993-09-30 | 1999-02-03 | Btg International Limited | Synthesis of 17-(3-pyridyl) steroids |
| ES2377074T3 (es) | 2004-08-24 | 2012-03-22 | Btg International Limited | Procedimiento para la preparación de 17-vinil-triflatos como intermedios |
| GB0418900D0 (en) | 2004-08-24 | 2004-09-29 | Btg Int Ltd | Novel salt forms |
| CN101768199B (zh) | 2009-12-24 | 2014-03-26 | 深圳万乐药业有限公司 | 醋酸阿比特龙的多晶型物及其制备方法 |
| CN102030798B (zh) | 2010-12-17 | 2012-10-17 | 深圳万乐药业有限公司 | 一种醋酸阿比特龙的纯化方法 |
| CN102558275A (zh) | 2010-12-20 | 2012-07-11 | 天津药物研究院 | α型多晶型醋酸阿比特龙结晶、其制备方法、用途和药物组合物 |
| CN102321142A (zh) | 2011-09-29 | 2012-01-18 | 重庆医药工业研究院有限责任公司 | 一种醋酸阿比特龙晶型及其制备方法 |
| HUE029523T2 (en) | 2011-10-10 | 2017-03-28 | Zach System | A method for preparing 17-substituted steroids |
| CN102336801B (zh) * | 2011-10-31 | 2013-05-15 | 南京卡文迪许生物工程技术有限公司 | 醋酸阿比特龙多晶型物和药用组合物 |
| CN102731605B (zh) | 2012-06-19 | 2016-04-13 | 鲁南制药集团股份有限公司 | 一种醋酸阿比特龙的纯化方法 |
-
2013
- 2013-04-19 HU HUE13305517A patent/HUE033085T2/en unknown
- 2013-04-19 PL PL13305517T patent/PL2792682T3/pl unknown
- 2013-04-19 RS RS20170114A patent/RS55673B1/sr unknown
- 2013-04-19 SI SI201330506A patent/SI2792682T1/sl unknown
- 2013-04-19 ES ES13305517.8T patent/ES2612780T3/es active Active
- 2013-04-19 EP EP13305517.8A patent/EP2792682B1/en active Active
-
2014
- 2014-04-11 US US14/785,110 patent/US9920089B2/en active Active
- 2014-04-11 CN CN201480022197.7A patent/CN105143241B/zh active Active
- 2014-04-11 WO PCT/EP2014/057375 patent/WO2014170221A1/en active Application Filing
-
2015
- 2015-10-18 IL IL242152A patent/IL242152B/en active IP Right Grant
-
2017
- 2017-01-27 HR HRP20170139TT patent/HRP20170139T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20160083416A1 (en) | 2016-03-24 |
| IL242152B (en) | 2018-08-30 |
| HRP20170139T1 (hr) | 2017-04-07 |
| CN105143241B (zh) | 2017-11-14 |
| CN105143241A (zh) | 2015-12-09 |
| ES2612780T3 (es) | 2017-05-18 |
| SI2792682T1 (sl) | 2017-03-31 |
| US9920089B2 (en) | 2018-03-20 |
| EP2792682A1 (en) | 2014-10-22 |
| EP2792682B1 (en) | 2016-11-09 |
| HUE033085T2 (en) | 2017-11-28 |
| RS55673B1 (sr) | 2017-06-30 |
| WO2014170221A1 (en) | 2014-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3006568T3 (pl) | Sposób wytwarzania tagatozy | |
| IL244426A0 (en) | Production method for a spirooxindole derivative | |
| HRP20170139T1 (hr) | Postupak dobivanja čvrstog oblika abirateron-acetata | |
| IL240748A0 (en) | Methods for generating adenovirus | |
| LT3003866T (lt) | Dozatoriaus gamybos būdas | |
| PL3013801T3 (pl) | Sposób stereoselektywnego wytwarzania pirazolo-karboksyamidu | |
| IL245649A0 (en) | A process for the preparation of ragdanosone | |
| HRP20170975T1 (hr) | Način proizvodnje goriva za energetiku | |
| TWI562728B (en) | A process for producing co-crystal | |
| EP3052616A4 (en) | A method of producing exosomes | |
| HK1219094A1 (zh) | 氟內酯衍生物配製過程 | |
| HUP1300566A2 (en) | Industrial process for producing steroid derivatives | |
| PL3418615T3 (pl) | Sposób wytwarzania systemu kanałowego | |
| GB2535004B (en) | A process for the preparation of Lenalidomide | |
| EP2938625A4 (en) | PROCESS FOR ABIRATERONACETATE | |
| EP3013844A4 (en) | Process for preparation of abiraterone acetate | |
| GB2514901B (en) | A method of producing refractory material | |
| HK1208864A1 (en) | A preparation method of ecteinascidin-743 intermediate -743 | |
| HUP1600376A2 (hu) | Eljárás tikagrelor elõállítására és a szintézis egy intermedierjének új kristályos formája | |
| AU2013903805A0 (en) | A method of producing exosomes |